CD34 and leukemia: To examine whether some of the potentially deleterious variants accumulated before leukaemia development, we screened 20 variants found with a high penetrance in both T2‐ALL and AML‐M0 clones by NGS on CD34+ cells obtained from the patient's peripheral blood 5 years prior to T2‐ALL development.